The rising interest in GLP-1 agonists for diabetes has sparked a discussion about application forms : transdermal systems versus tablets . Usually , GLP-1 treatments were exclusively available in tablet https://lulusyzo153430.elbloglibre.com/41317103/glp-1-patches-vs-tablets-is-right-for-the-patient